Ignite Creation Date:
2024-05-05 @ 9:42 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00008775
Status:
SUSPENDED
Last Update Posted:
2005-06-24
First Post:
2001-01-16
Brief Title:
Pressure Support Ventilation During CF Exacerbations
Sponsor:
National Center for Research Resources NCRR
Organization:
National Center for Research Resources NCRR
Study Overview
Official Title:
Pressure Support Ventilation During CF Exacerbations A Randomized Controlled Trial
Status:
SUSPENDED
Status Verified Date:
2001-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Chest physiotherapy is recognized as a mainstay of cystic fibrosis therapy and is particularly important during treatment of pulmonary exacerbations For some patients especially those with moderate to severe compromise of lung function this therapy may impose a high demand in the work of breathing and energy expenditure The goal of this study is to evaluate the effectiveness of adding pressure support ventilation PSV during chest physiotherapy sessions in patients with cystic fibrosis with moderate to severe lung function compromise being treated for a pulmonary exacerbation
Detailed Description:
The proposed study will be conducted over three years Cystic fibrosis patients with moderate to severe pulmonary disease who are experiencing an acute exacerbation that requires hospitalization will be admitted to the GCRC Subject participation in the study will be for the first 10 days of hospitalization Subjects will be randomized into one of two treatment groups usual care or usual care plus non-invasive pressure support ventilation PSV
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: